ORIGINAL ARTICLE
The role of histology, grading, location of tumour and ploidy in evaluation of outcome in patients with liposarcoma
Publication date: 2018-03-06
Pol J Pathol 2017;68(4):343-351
KEYWORDS
ABSTRACT
Department of Tumour Pathology, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Kraków, Poland
The review of literature indicates that several clinico-morphological factors such as location of the primary tumour as well as its size, histologic subtype, and grade or even selected molecular changes may significantly affect survival of liposarcoma (LPS) patients. Data concerning prognostic importance of DNA ploidy status in LPS cells are extremely limited and results of flow cytometry (FCM) studies have never been compiled with the current classification of malignant adipocytic tumours.
Based on evaluation of material from 54 liposarcomas which was available for both histological and FCM analysis, we distinguished four prognostic groups of patients. The best prognosis was noticed for diploid and grade G1 well-differentiated or myxoid liposarcomas localised on extremities. None of the patients with lipoma-like WDLPS and myxoid liposarcoma grade 1 metastasised, while metastases were observed among patients with dedifferentiated LPS (70% of 5-year MFS) and cellular myxoid or round cell liposarcoma (20% of 5-year MFS, only). The metastasis-free survival curves for the above mentioned groups of patients differed significantly (p = 0.00001)
The review of literature indicates that several clinico-morphological factors such as location of the primary tumour as well as its size, histologic subtype, and grade or even selected molecular changes may significantly affect survival of liposarcoma (LPS) patients. Data concerning prognostic importance of DNA ploidy status in LPS cells are extremely limited and results of flow cytometry (FCM) studies have never been compiled with the current classification of malignant adipocytic tumours.
Based on evaluation of material from 54 liposarcomas which was available for both histological and FCM analysis, we distinguished four prognostic groups of patients. The best prognosis was noticed for diploid and grade G1 well-differentiated or myxoid liposarcomas localised on extremities. None of the patients with lipoma-like WDLPS and myxoid liposarcoma grade 1 metastasised, while metastases were observed among patients with dedifferentiated LPS (70% of 5-year MFS) and cellular myxoid or round cell liposarcoma (20% of 5-year MFS, only). The metastasis-free survival curves for the above mentioned groups of patients differed significantly (p = 0.00001)
REFERENCES (18)
1.
Fletcher CDM, Bridge JA, Hogendoorn PCW,et al. WHO Classification of Tumours of Soft Tissue and Bone. IARC, Lyon 2013.
2.
Knebel C, Lenze U, Pohlig F, et al. Prognostic factors and outcome of liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer 2017; 17: 410.
3.
Tirumani SH, Tirumani H, Jagannathan JP, et al. Metastasis in dedifferentiated liposarcoma: Predictors and outcome in 148 patients. Eur J Surg Oncol 2015; 41: 899-904.
4.
Ricciotti RW, Baraff AJ, Jour G, et al. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases. Cancer Genet 2017; 218-219: 69-80.
5.
Kapodistrias N, Mavridis K, Batistatou A, et al. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis. Oncotarget 2017; 8: 6896-6913.
6.
Nezu Y, Hagiwara K, Yamamoto Y, et al. miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma. Oncogene 2016; 35: 6177-6188.
7.
Kim JH, Lee JS, Kim EJ, et al. Prognostic implications of PIK3CA amplification in curatively resected liposarcoma. Oncotarget 2016; 7: 24549-24558.
8.
Amin MB, Edge S, Greene F, et al. (eds.). AJCC Cancer Staging Manual, Springer 2017.
9.
Callegaro D, Micelli R, Mariani L, et al. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer 2017; 123: 2802-2820.
10.
Dalal KM, Kattan MW, Antonescu CR. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244: 381-391.
11.
Dreinhöfer KE, Baldetorp B, Akerman M, et al. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Cytometry 2002; 50: 19-24.
12.
Shankey TW, Rabinovith PS, Bagwell, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993, 14: 47.
13.
Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997; 21: 271-281.
14.
Elgar F, Goldblum JR. Well-deifferentiated liposarcoma of the retroperitioneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation. Mod Pathol 1997; 10: 113-120.
15.
Hisaoka M, Morimitsu Y, Hashimoto H, et al. Retriperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas. Am J Surg Pathol 1999; 23: 1480-1492.
16.
Hasegawa T, Seki K, Hasegawa F, et al. Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histologic grades – a clinicopathologic study of 32 cases. Hum Pathol 2000; 31: 717-727.
17.
Huang HY, Brennan MF, Singer S, et al. Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathologic study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol 2005; 18: 976-984.
18.
Evans HL. Atypical lipomatous tumor, its variants and its combined forms. A study of 61 cases, with minimum follow-up of 10 years. Am J Surg Pathol 2007; 31: 1-14.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
